The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Arcutis Biotherapeutics Inc shares valued at $21,137 were sold by Watanabe Todd Franklin on Mar 17 ’25. At $17.61 per share, Watanabe Todd Franklin sold 1,200 shares. The insider’s holdings dropped to 928,914 shares worth approximately $15.58 million following the completion of this transaction.
Also, Watanabe Todd Franklin purchased 1,200 shares, netting a total of over 21,137 in proceeds.
Before that, Burnett Patrick had sold 49,161 shares from its account. In a trade valued at $736,403, the insider traded Arcutis Biotherapeutics Inc shares for $14.98 each. Upon closing the transaction, the insider’s holdings decreased to 49,161 shares, worth approximately $2.04 million.
As published in their initiating research note from H.C. Wainwright on December 30, 2024, Arcutis Biotherapeutics Inc [ARQT] has been a Buy and the price target has been revised to $19. Analysts at Jefferies started covering the stock with ‘”a Buy”‘ outlook in a report released in late August. As of January 03, 2024, Mizuho has increased its “Neutral” rating to a “Buy” for ARQT. Earlier on October 26, 2023, Mizuho downgraded its rating. Their new recommendation was “a Neutral” for ARQT stock which previously was a “a Buy”.
Analyzing ARQT Stock Performance
During the last five days, there has been a surge of approximately 13.23%. Over the course of the year, Arcutis Biotherapeutics Inc shares have jumped approximately 20.39%. Shares of the company reached a 52-week high of $17.70 on 03/17/25 and a 52-week low of $11.13 on 02/11/25. A 50-day SMA is recorded $13.72, while a 200-day SMA reached $11.11.
Support And Resistance Levels for Arcutis Biotherapeutics Inc (ARQT)
According to the 24-hour chart, there is a support level at 16.43, which, if violated, would cause prices to drop to 16.10. In the upper region, resistance lies at 17.30. The next price resistance is at 17.84. RSI (Relative Strength Index) is 64.83 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 1.39, which suggests the price will increase in the coming days. Percent R is at 17.06%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
